Mark Elliott Boulding - Jan 10, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
EXEC. VP AND CLO
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Jan 10, 2023
Transactions value $
-$47,288
Form type
4
Date filed
1/12/2023, 03:38 PM
Previous filing
Jan 11, 2023
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$25.3K -590 -0.76% $42.93 76.7K Jan 10, 2023 Direct F1
transaction PTCT Common Stock Sale -$22K -495 -0.65% $44.36 76.2K Jan 11, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.